
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on February 07, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,161 cr
Turnover Ratio
16.09%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -6.11%
- 1Y: 17.06%
- 3M: -3.15%
- 3Y: 21.31%
- 6M: 0.67%
- 5Y: 26.32%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
486.288 | 28.60% | 3,522 cr | 0.89% | - |
Other plans of Nippon India Pharma